Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2025-12-24 @ 12:04 PM
Study NCT ID:
NCT03832361
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2019-02-04
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Sponsor:
Alessandro Santin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-04
First Submit QC Date:
None
Study First Post Date:
2019-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-15
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL